CC
GILD icon

Coastland Capital’s Gilead Sciences GILD Stock Holding History

Coastland Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-79,000
Closed -$8.63M – 207
2015
Q1 		$7.75M Buy
+79,000
New +$8.02M 0.26% 95

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Coastland Capital's GILD Position: Q2 2015 in Review

Coastland Capital sold out of Gilead Sciences (GILD) in Q2 2015, closing a stake of 79,000 shares — an estimated $8.63M sold.

Coastland Capital first reported a position in GILD in Q1 2015 and held it in 1 quarter. The position peaked at $7.75M in Q1 2015. 1,560 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Coastland Capital reported no remaining Gilead Sciences position as of Q2 2015 after selling out during the quarter.
  • Coastland Capital sold 79,000 Gilead Sciences shares in Q2 2015, an estimated $8.63M.
  • Coastland Capital first reported a position in Gilead Sciences in Q1 2015 and held it in 1 quarter.
  • Coastland Capital's Gilead Sciences position peaked at $7.75M in Q1 2015.
  • 1,560 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Coastland Capital's 13F filing for Q2 2015, filed 14 Aug 2015.